Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sanofi
SNY
$103B
| $863M | 0.54% |
17,906,429
+21,337
| +0.1% | +$1.08M |
|
52
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.6B
| $853M | 0.53% |
20,670,136
+1,752,094
| +9% | +$74.4M |
|
53
Toyota
TM
$224B
| $853M | 0.53% |
4,799,418
+165,451
| +4% | +$29.5M |
|
54
Novartis
NVS
$292B
| $843M | 0.52% |
10,305,029
+342,603
| +3% | +$30.8M |
|
|
RDS.A
55
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $809M | 0.5% |
18,152,827
+700,705
| +4% | +$28.3M |
|
56
Capital One
COF
$136B
| $801M | 0.5% |
4,945,156
+931,872
| +23% | +$152M |
|
57
Merck
MRK
$315B
| $799M | 0.5% |
10,633,264
+316,452
| +3% | +$24.1M |
|
58
Stryker
SYK
$128B
| $785M | 0.49% |
2,975,851
+136,142
| +5% | +$36.4M |
|
59
Invesco QQQ Trust
QQQ
$481B
| $729M | 0.45% |
2,036,029
+129,433
| +7% | +$47.7M |
|
60
Edwards Lifesciences
EW
$51.2B
| $727M | 0.45% |
6,424,697
+267,356
| +4% | +$30.5M |
|
61
GSK
GSK
$103B
| $681M | 0.42% |
14,264,320
+225,927
| +2% | +$11.3M |
|
62
ING
ING
$102B
| $672M | 0.42% |
46,377,692
+2,201,849
| +5% | +$29.4M |
|
63
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
| $665M | 0.41% |
21,280,924
+398,608
| +2% | +$12.5M |
|
64
Chevron
CVX
$380B
| $634M | 0.39% |
6,253,880
+223,476
| +4% | +$22.3M |
|
65
RTX Corp
RTX
$291B
| $616M | 0.38% |
7,168,608
+454,524
| +7% | +$38.9M |
|
|
ABB
66
DELISTED
ABB Ltd
ABB
| $584M | 0.36% |
17,501,279
+676,372
| +4% | +$24.6M |
|
67
American Tower
AMT
$81.4B
| $524M | 0.33% |
1,973,945
+49,959
| +3% | +$14.2M |
|
68
JD.com
JD
$44.3B
| $520M | 0.32% |
7,204,333
-268,447
| -4% | -$19.8M |
|
69
iShares National Muni Bond ETF
MUB
$45.4B
| $517M | 0.32% |
4,453,159
+396,014
| +10% | +$46.4M |
|
70
ExxonMobil
XOM
$634B
| $516M | 0.32% |
8,773,819
+313,683
| +4% | +$17.9M |
|
71
CSX Corp
CSX
$93.2B
| $510M | 0.32% |
17,155,489
+798,279
| +5% | +$25.6M |
|
72
Vale
VALE
$63.2B
| $486M | 0.3% |
34,864,170
-1,837,856
| -5% | -$36.1M |
|
73
SLB Ltd
SLB
$74.9B
| $478M | 0.3% |
16,130,140
+614,114
| +4% | +$17.6M |
|
74
Alphabet (Google) Class C
GOOG
$4.57T
| $463M | 0.29% |
3,472,060
-68,860
| -2% | -$9.49M |
|
75
AB InBev
BUD
$166B
| $462M | 0.29% |
8,196,167
-269,279
| -3% | -$16.9M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.